Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-26-051739
Filing Date
2026-04-29
Accepted
2026-04-29 17:15:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2612147-4_424b3.htm 424B3 239827
2 GRAPHIC lg_apreatherapeutic-4c.jpg GRAPHIC 16093
  Complete submission text file 0001104659-26-051739.txt   262820
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-295247 | Film No.: 26918036
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)